| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |